Patient Access Solutions Inc. Update for Shareholders

Hauppauge, NY -- July 05,2016 -- InvestorsHub NewsWire -- Patient Access Solutions, Inc. (PASO), a provider of healthcare/financial processing solutions for the healthcare, and dental industries, announced today an update for its’ Shareholders.

It has been a while since we have updated our Shareholders on the status of the Company and felt it is the appropriate time to do so.

While the Company has been dormant, for the most part over the past 2 years, the core business has been staying on the books. We have spent the past few years looking for the right opportunity to expand this core business. We believe that what we have developed will not only be profitable, but scalable.

Patient Access Solutions Inc. through its management company PASHealth Management Company Inc., will open the Plainview Center; Specializing in the treatment of Autism, Concussion, PTSD and numerous other biomedical conditions. The Center will offer innovative healthcare strategies for children with autism and additionally implement novel and effective strategies of rehabilitation for post-concussion syndrome and like syndromes. The Center will be run by two well renowned doctors from Long Island. The date of the opening of the Center is not confirmed as of yet, but we expect by the beginning of fourth quarter 2016. The Company plans to build additional locations on a nationwide basis, encompassing the protocols of these two doctors.

In the past, many families with children with Autism were unable to afford services, due to the fact that the services provided wer not covered by insurance. However, these children, and their families, will now be able to afford these treatments as N.Y. State has now caught up with many other states in allotting monies for families with Autistic children, $45,000 each child per family per year. (http://www.ncsl.org/research/health/autism-and-insurance-coverage-state-laws.aspx) Our goal is to treat a minimum of 400 children annually.

The Company's current plan is to return to being a fully reporting public company and file annual and quarterly reports pursuant to the Securities Act of 1934, as amended and proceed to have the stock traded on the OTCQB. At this time, there is no guarantee as to the date when this will be completed.

The Company's stock is currently listed on the Pink Sheets.

"We're pleased to announce this significant step in the continued, overall progress of Patient Access Solutions Inc.," said Bruce Weitzberg, President and CEO of PAS. "We believe that achieving these goals will provide us with enhanced credibility and help us showcase the Company.”

About Patient Access Solutions Inc.(www.pashealth.com)
Patient Access Solutions Inc. (PASHealth) is a Healthcare Solutions company which has created a formidable array of technology, resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment. For more information about the services and products of Patient Access Solutions, please visit our website at www.pashealth.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at http://www.sec.gov.

Investor Information
631-241-9404